Safety and immunogenicity of the purified Vero rabies vaccine next generation in chinese Pediatric (≥ 10 years) and adult populations

Main Article Content

S. Pichon
R. Li
J. Li
J. D. Shu
P. Chavand
M. Minutello
F. Guinet-Morlot

Abstract

The Purified Vero cell Rabies Vaccine Next Generation (PVRV-NG) is a highly purified vaccine developed with innovative technology and human and animal origin components-free medium. It was shown to be at least as immunogenic as Verorab™ and presented a similar safety profile in a phase II clinical study conducted in France (pre exposure regimen). A phase III clinical study was performed in Chinese pediatric (≥ 10 years) and adult populations in simulated post-exposure regimen to further document PVRV-NG in comparison to Verorab™.

Article Details

How to Cite
PICHON, S.; LI, R.; LI, J.; SHU, J. D.; CHAVAND, P.; MINUTELLO, M.; GUINET-MORLOT, F. Safety and immunogenicity of the purified Vero rabies vaccine next generation in chinese Pediatric (≥ 10 years) and adult populations. Revista de Educação Continuada em Medicina Veterinária e Zootecnia, v. 10, n. 2/3, p. 53-54, 11.
Section
RITA ABSTRACTS